ArticleJournal of Cancer2019
CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients.
Li-Ming Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleJournal of Cancer2019
Li-Ming Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.